Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from cbdMD ( (YCBD) ) is now available.
cbdMD, Inc. announced the appointment of T. Ronan Kennedy, its current CEO and CFO, to the Board of Directors, expanding it to five members. Under Kennedy’s leadership, the company has stabilized, optimized its cost structure, and improved operational fundamentals, positioning itself for long-term success. His appointment is expected to enhance the company’s strategic capabilities and shareholder value.
More about cbdMD
cbdMD, Inc. is a prominent CBD company known for its highly trusted and recognized cannabidiol (CBD) brands, including cbdMD and Paw CBD. The company offers a wide range of U.S.-produced, THC-free CBD products, such as tinctures, gummies, topicals, capsules, and more, as well as veterinarian-formulated pet products. Additionally, cbdMD’s ATRx Labs brand focuses on natural functional mushroom support.
YTD Price Performance: -65.38%
Average Trading Volume: 355,063
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.99M
For an in-depth examination of YCBD stock, go to TipRanks’ Stock Analysis page.
